GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hi-Crates Co 4172.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,135

+1.67%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2025

Revenue

¥2.41bn

FY2018FY2025

Net income

¥448.1m

FY2018FY2025

Free cash flow

¥420.2m

FY2018FY2025

Shareholders' equity

¥4.20bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue¥2.41bn¥2.11bn¥2.04bn¥2.22bn¥2.37bn¥1.91bn¥1.91bn¥2.04bn
Gross profit¥1.85bn¥1.60bn¥1.46bn¥1.63bn¥1.78bn¥1.50bn¥1.46bn¥1.59bn
Research and development—¥52.0m¥52.0m¥6.5m¥2.5m¥4.7m¥7.2m¥6.5m
Operating income¥549.6m¥422.2m¥230.9m¥416.5m¥601.6m¥384.2m¥381.6m¥457.4m
Net income¥448.1m¥401.8m¥258.5m¥316.3m¥375.6m¥245.5m¥237.4m¥303.3m
Diluted earnings per share201.14180.35116.03141.95168.57123.65106.57136.15

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets¥4.73bn¥4.38bn¥4.06bn¥4.05bn¥4.02bn¥3.09bn¥2.81bn¥3.01bn
Cash and short-term investments¥2.10bn¥1.61bn¥1.60bn¥1.80bn¥2.16bn¥2.04bn¥1.68bn¥1.79bn
Total liabilities¥531.1m¥447.1m¥327.8m¥456.0m¥521.7m¥445.7m¥366.6m¥767.4m
Debt——¥7.2m————¥343.1m
Shareholders' equity¥4.20bn¥3.93bn¥3.73bn¥3.59bn¥3.50bn¥2.65bn¥2.44bn¥2.25bn
Shares outstanding2m2m2m2m2m2m2m2m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations¥461.2m¥504.4m¥61.1m¥342.7m¥248.0m¥430.1m¥282.2m¥290.4m
Capital spending−¥41.0m−¥13.8m−¥176.9m−¥98.8m−¥125.3m−¥28.8m−¥8.4m−¥226.3m
Free cash flow¥420.2m¥490.6m−¥115.8m¥243.9m¥122.7m¥401.3m¥273.7m¥64.1m
Dividends paid−¥227.1m−¥178.2m−¥95.8m−¥222.7m−¥68.9m−¥41.0m−¥41.0m−¥55.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥635.1m¥646.8m¥632.4m¥652.0m¥518.1m¥625.5m¥611.0m¥529.0m
Gross profit¥481.2m¥510.8m¥498.4m¥514.0m¥375.0m¥480.7m¥483.0m¥393.0m
Operating income¥128.1m¥191.7m¥188.0m¥133.1m¥71.4m¥175.0m¥170.0m¥77.0m
Net income¥132.7m¥145.1m¥136.1m¥107.4m¥63.3m¥142.3m¥135.0m¥71.0m
Diluted earnings per share59.5865.1261.0948.2328.4263.8960.6031.87
Cash from operations———¥461.0m————
Capital spending———−¥41.0m————
Free cash flow———¥420.0m————
Total assets¥5.11bn¥4.85bn¥4.58bn¥4.73bn¥4.56bn¥4.52bn¥4.34bn¥4.38bn
Cash and short-term investments¥1.68bn¥1.76bn¥1.65bn¥2.10bn¥1.44bn¥1.80bn¥1.39bn¥1.61bn
Shareholders' equity¥4.40bn¥4.36bn¥4.23bn¥4.20bn¥4.08bn¥4.12bn¥3.98bn¥3.93bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin77.0%75.8%71.5%73.5%75.3%78.5%——
Operating margin27.0%20.0%11.3%21.6%22.8%20.1%——
Net margin18.6%19.0%12.7%14.3%15.8%12.9%——
Return on equity10.7%10.2%6.9%8.8%10.7%9.3%——
Return on assets9.5%9.2%6.4%7.8%9.3%7.9%——
Free cash flow yield9.5%10.3%1.3%7.0%5.1%9.9%——
Revenue growth13.9%3.5%-7.8%-6.5%24.1%0.2%——
Earnings growth11.5%55.4%-18.3%-15.8%53.0%3.4%——
Current ratio5.24x5.12x8.27x5.54x5.61x5.52x——
Debt to equity——0.00x0.00x0.00x0.00x—0.03x
Equity ratio88.8%89.8%91.9%88.7%87.0%85.6%——
Interest coverage———28.28x57.53x27.48x3864.58x540.56x
R&D as a share of sales—2.5%2.5%0.3%0.1%0.2%0.4%—
Buybacks as a share of market value0.0%0.0%0.0%0.0%-12.2%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2.8%4.7%—
Operating income9.7%7.4%—
Net income12.3%12.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin76.4%74.6%75.3%—
Operating margin21.5%18.4%20.0%—
Net margin18.8%16.2%15.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings11.710.513.410.415.327.3
Price to sales2.22.01.71.52.43.5

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year88.00102.0080.0043.0085.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.